| API | Orukọ ọja | ỌJỌ RỌRỌ. | Iyasọtọ |
| Canagliflozin | 2- (4-Fluorophenyl) -5-[(5-iodo-2-methylphenyl) methyl] thiophene | 898566-17-1 | Àtọgbẹ |
| Empagliflozin | (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan | 915095-89-5 | Àtọgbẹ |
| Linagliptin | 8-bromo-7- (ṣugbọn-2-ynyl) -3-methyl-1H-purine-2,6 (3H,7H) -dione | 666816-98-4 | Àtọgbẹ |
| Linagliptin | 2- (chloromethyl) -4-methylquinazoline | 109113-72-6 | Àtọgbẹ |
| Linagliptin | 8-Bromo-7-ṣugbọn-2-ynyl-3-methyl-1- (4-methyl-quinazolin-2-ylmethyl) -3,7-dihydro-purine-2,6-dione | 853029-57-9 | Àtọgbẹ |
| Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo [3.1.0] hexane-2-carboxylic acid tert-butyl ester | 361440-67-7 | Àtọgbẹ |
| Saxagliptin | (alphaS) -alpha-[[(1,1-Dimethylethoxy) carbon] amino] -3-hydroxytricyclo[3.3.1.13,7] decane-1-acetic acid | 361442-00-4 | Àtọgbẹ |
| Sitagliptin | 2,4,5-Trifluorophenylacetic acid | 209995-38-0 | Àtọgbẹ |
| Sitagliptin | Boc-(R) -3-Amino-4- (2,4,5-Trifluoro-Phenyl) -Butyric Acid | 486460-00-8 | Àtọgbẹ |
| Sitagliptin | 3- (Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4] triazolo [4,3-a] pyrazine hydrochloride | 762240-92-6 | Àtọgbẹ |
| Vildagliptin | L-Prolinamide | 7531-52-4 | Àtọgbẹ |
| Vildagliptin | (2S) -1- (Chloroacetyl) -2-pyrrolidinecarbonitrile | 207557-35-5 | Àtọgbẹ |
| Empagliflozin Dapagliflozin/Canagliflozin | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 | Àtọgbẹ |
| Vildagliptin | L-Prolinamide | 7531-52-4 | Àtọgbẹ |
| Liraglutide | Liraglutide | 204656-20-2 | Àtọgbẹ |
| ABT-888 | (S) -2-Methylproline | 42856-71-3 | Anti-akàn |
| Docetaxel | 10-Deacetylbaccatin III | 32981-86-5 | Anti-akàn |
| Lenvatinib | 4-chloro-7-methoxyquinoline-6-carboxamide | 417721-36-9 | Anti-akàn |
| Lenvatinib | 4-Amino-3-chlorophenol hydrochloride | 52671-64-4 | Anti-akàn |
| Akalabrutinib | (3-Chloropyrazin-2-yl) MethanaMine hydrochloride | 939412-86-9 | Anti-akàn |
| Akalabrutinib | N-Benzyloxycarbonyl-L-proline | 1148-11-4 | Anti-akàn |
| Akalabrutinib | N-Pyridin-2-yl-4- (4,4,5,5-tetramethyl-[1,3,2] dioxaborolan-2-yl) -benzamide | 1383385-64-5 | Anti-akàn |
| Akalabrutinib | 2-Butynoic acid | 590-93-2 | Anti-akàn |
| Nilotinib | 3- (4-Methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline | 641571-11-1 | Anti-akàn |
| Nilotinib | Diphenylphosphoryl azide | 26386-88-9 | Anti-akàn |
| Nilotinib | 4-Methyl-3-[[4- (3-pyridinyl)-2-pyrimidinyl] amino] benzoic acid | 641569-94-0 | Anti-akàn |
| Nilotinib | 1- (3-Pyridyl) -3- (dimethylamino) -2-propen-1-ọkan | 55314-16-4 | Anti-akàn |
| Abiraterone acetate | 17-Iodoandrosta-5,16-dien-3beta-ol | 32138-69-5 | Anti-akàn |
| Abiraterone acetate | 17-Iodoandrosta-5,16-dien-3beta-ol 3-acetate | 114611-53-9 | Anti-akàn |
| Neratinib | 3-chloro-4- (pyridin-2-ylmethoxy) aniline | 524955-09-7 | Anti-akàn |
| Neratinib | N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide | 848133-76-6 | Anti-akàn |
| Neratinib | 6-amino-4- (3-chloro-4- (pyridin-2-ylmethoxy) phenylamino) -7-ethoxyquinoline-3-carbonitrile | 848139-78-6 | Anti-akàn |
| Neratinib | trans-4-Dimethylaminocrotonic acid hydrochloride | 848133-35-7 | Anti-akàn |
| Palbociclib | tert-butyl 4- (6-amino-3-pyridyl) piperazine-1-carboxylate | 571188-59-5 | Anti-akàn |
| Palbociclib | 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d] pyrimidin-7(8H) -ọkan | 1016636-76-2 | Anti-akàn |
| Ribociclib | 2-Chloro-7-cyclopentyl-n, n-dimethyl-7h-pyrrolo [2,3d] pyrimidine-6-carboxamide | 1211443-61-6 | Anti-akàn |
| Ribociclib | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d] pyrimidine-6-carboxylic acid | 1211443-58-1 | Anti-akàn |
| Certinib/Crizotinib | 4- (4-Bromopyrazol-1-yl) piperidine-1-carboxylic acid tert-butyl ester | 877399-50-3 | Anti-akàn |
| Certinib/Crizotinib | tert-Butyl 4- [4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrasol-1-yl] piperidine-1-carboxylate | 877399-74-1 | Anti-akàn |
| Certinib/Crizotinib | (S) -1- (2,6-Dichloro-3-fluorophenyl) ethanol | 877397-65-4;42247-74-5 | Anti-akàn |
